Correction: Aberrant iPSC-derived human astrocytes in Alzheimer's disease (Cell Death & Disease, (2017), 8, 3, (e2696), 10.1038/cddis.2017.89);Aberrant iPSC-derived human astrocytes in Alzheimer's disease

Cell Death and Disease

Volumn 8, Issue 3, 2017, Pages

  Jones, V C ^a   Atkinson Dell, R ^b   Verkhratsky, A ^b,c   Mohamet, L ^b  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 1; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN S100B; RANTES; TISSUE INHIBITOR OF METALLOPROTEINASE 2; BIOLOGICAL MARKER;

ADULT; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; ATROPHY; CELL LINEAGE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INDUCED PLURIPOTENT STEM CELL; MACROGLIA; MODEL; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL CULTURE; CELL DIFFERENTIATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; STEM CELL; UPREGULATION;

ALZHEIMER DISEASE; ASTROCYTES; ATROPHY; BIOMARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; EXCITATORY AMINO ACID TRANSPORTER 1; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE-AMMONIA LIGASE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MIDDLE AGED; NEURAL STEM CELLS; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; STEM CELLS; UP-REGULATION;

EID: 85032735977     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/s41419-019-1422-7     Document Type: Erratum

References (47)

1. Verkhratsky A, Butt AM. Glial Physiology and Pathophysiology. Wiley-Blackwell: Chichester, UK, 2013.
2. Zhou Y, Danbolt NC. GABA and Glutamate Transporters in Brain. Front Endocrinol 2013; 4: 165.
3. Burda JE, Bernstein AM, Sofroniew MV. Astrocyte roles in traumatic brain injury. Exp Neurol 2016; 275(Pt 3): 305–315.
4. Sofroniew MV. Astrogliosis. Cold Spring Harb Perspect Biol 2015; 7: a020420.
5. Pekny M, Pekna M, Messing A, Steinhauser C, Lee JM, Parpura V et al. Astrocytes: a central element in neurological diseases. Acta Neuropathol 2016; 131: 323–345.
6. Verkhratsky A, Sofroniew MV, Messing A, deLanerolle NC, Rempe D, Rodriguez JJ et al. Neurological diseases as primary gliopathies: a reassessment of neurocentrism. ASN Neuro 2012; 4: e00082.
7. Chung WS, Welsh CA, Barres BA, Stevens B. Do glia drive synaptic and cognitive impairment in disease? Nat Neurosci 2015; 18: 1539–1545.
8. Molofsky AV, Krencik R, Ullian EM, Tsai HH, Deneen B, Richardson WD et al. Astrocytes and disease: a neurodevelopmental perspective. Genes Dev 2012; 26: 891–907.
9. Verkhratsky A, Olabarria M, Noristani HN, Yeh CY, Rodriguez JJ. Astrocytes in Alzheimer's disease. Neurotherapeutics 2010; 7: 399–412.
10. Olabarria M, Noristani HN, Verkhratsky A, Rodriguez JJ. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia 2010; 58: 831–838.
11. Beauquis J, Pavia P, Pomilio C, Vinuesa A, Podlutskaya N, Galvan V et al. Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease. Exp Neurol 2013; 239: 28–37.
12. Beauquis J, Vinuesa A, Pomilio C, Pavia P, Galvan V, Saravia F. Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease. Hippocampus 2014; 24: 257–269.
13. Rodriguez-Vieitez E, Leuzy A, Chiotis K, Saint-Aubert L, Wall A, Nordberg A. Comparability of [18 F]THK5317 and [11C]PIB blood flow proxy images with [18 F]FDG positron emission tomography in Alzheimer's disease. J Cereb Blood Flow Metab 2016; 37: 740–749.
14. Verkhratsky A, Marutle A, Rodríguez-Arellano JJ, Nordberg A. Glial asthenia and functional paralysis. A new perspective on neurodegeneration and Alzheimer’s disease. Neuroscientist 2015; 21: 552–568.
15. Gotz J, Ittner LM. Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 2008; 9: 532–544.
16. Oberheim NA, Takano T, Han X, He W, Lin JH, Wang F et al. Uniquely hominid features of adult human astrocytes. The J Neuroscience 2009; 29: 3276–3287.
17. Zhang PW, Haidet-Phillips AM, Pham JT, Lee Y, Huo Y, Tienari PJ et al. Generation of GFAP::GFP astrocyte reporter lines from human adult fibroblast-derived iPS cells using zinc-finger nuclease technology. Glia 2016; 64: 63–75.
18. Shaltouki A, Peng J, Liu Q, Rao MS, Zeng X. Efficient generation of astrocytes from human pluripotent stem cells in defined conditions. Stem Cells 2013; 31: 941–952.
19. Krencik R, Zhang SC. Directed differentiation of functional astroglial subtypes from human pluripotent stem cells. Nat Protoc 2011; 6: 1710–1717.
20. Roybon L, Lamas NJ, Garcia-Diaz A, Yang EJ, Sattler R, Jackson-Lewis V et al. Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes. Cell Rep 2013; 4: 1035–1048.
21. Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y et al. Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness. Cell Stem Cell 2013; 12: 487–496.
22. Liao MC, Muratore CR, Gierahn TM, Sullivan SE, Srikanth P, De Jager PL et al. Single-cell detection of secreted Abeta and sAPPalpha from human IPSC-derived neurons and astrocytes. J Neurosci 2016; 36: 1730–1746.
23. Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C et al. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 2012; 482: 216–220.
24. Shi Y, Kirwan P, Livesey FJ. Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks. Nat Protoc 2012; 7: 1836–1846.
25. Mohamet L, Miazga NJ, Ward CM. Familial Alzheimer's disease modelling using induced pluripotent stem cell technology. World J Stem Cells 2014; 6: 239–247.
26. Michler-Stuke A, Wolff JR, Bottenstein JE. Factors influencing astrocyte growth and development in defined media. Int J Dev Neurosci 1984; 2: 575–584.
27. Sanalkumar R, Vidyanand S, Lalitha Indulekha C, James J. Neuronal vs. glial fate of embryonic stem cell-derived neural progenitors (ES-NPs) is determined by FGF2/EGF during proliferation. J Mol Neurosci 2010; 42: 17–27.
28. Bradford J, Shin JY, Roberts M, Wang CE, Sheng G, Li S et al. Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice. J Biol Chem 2010; 285: 10653–10661.
29. Chen PC, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW et al. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Proc Natl Acad Sci USA 2009; 106: 2933–2938.
30. Liu H, Zhang SC. Specification of neuronal and glial subtypes from human pluripotent stem cells. Cell Mol Life Sci 2011; 68: 3995–4008.
31. Miguel-Hidalgo JJ, Wei J, Andrew M, Overholser JC, Jurjus G, Stockmeier CA et al. Glia pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms. Biol Psychiatry 2002; 52: 1121–1133.
32. Burbaeva G, Boksha IS, Tereshkina EB, Savushkina OK, Starodubtseva LI, Turishcheva MS. Glutamate metabolizing enzymes in prefrontal cortex of Alzheimer's disease patients. Neurochem Res 2005; 30: 1443–1451.
33. Revett TJ, Baker GB, Jhamandas J, Kar S. Glutamate system, amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. J Psychiatry Neurosci 2013; 38: 6–23.
34. Kulijewicz-Nawrot M, Sykova E, Chvatal A, Verkhratsky A, Rodriguez JJ. Astrocytes and glutamate homoeostasis in Alzheimer's disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex. ASN Neuro 2013; 5: 273–282.
35. Emsley JG, Macklis JD. Astroglial heterogeneity closely reflects the neuronal-defined anatomy of the adult murine CNS. Neuron Glia Biol 2006; 2: 175–186.
36. Kulijewicz-Nawrot M, Verkhratsky A, Chvatal A, Sykova E, Rodriguez JJ. Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer's disease. J Anatomy 2012; 221: 252–262.
37. Yeh CY, Vadhwana B, Verkhratsky A, Rodriguez JJ. Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease. ASN Neuro 2011; 3: 271–279.
38. Choi SS, Lee HJ, Lim I, Satoh J, Kim SU. Human astrocytes: secretome profiles of cytokines and chemokines. PLoS ONE 2014; 9: e92325.
39. Meeuwsen S, Persoon-Deen C, Bsibsi M, Ravid R, van Noort JM. Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia 2003; 43: 243–253.
40. Andoh-Noda T, Akamatsu W, Miyake K, Matsumoto T, Yamaguchi R, Sanosaka T et al. Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage. Mol Brain 2015; 8: 31.
41. Chang CY, Chen SM, Lu HE, Lai SM, Lai PS, Shen PW et al. N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons. Sci Rep 2015; 5: 8744.
42. Hossini AM, Megges M, Prigione A, Lichtner B, Toliat MR, Wruck W et al. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks. BMC Genomics 2015; 16: 84.
43. Li T, Pires C, Nielsen TT, Waldemar G, Hjermind LE, Nielsen JE et al. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1. Stem Cell Res 2016; 16: 334–337.
44. Schroter F, Sleegers K, Van Cauwenberghe C, Bohndorf M, Wruck W, Van Broeckhoven C et al. Lymphoblast-derived integration-free iPSC lines from a female and male Alzheimer's disease patient expressing different copy numbers of a coding CNV in the Alzheimer risk gene CR1. Stem Cell Res 2016; 17: 560–563.
45. Zhang D, Pekkanen-Mattila M, Shahsavani M, Falk A, Teixeira AI, Herland A. A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons. Biomaterials 2014; 35: 1420–1428.
46. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T et al. Fiji: an open-source platform for biological-image analysis. Nat Methods 2012; 9: 676–682.
47. Schindelin J, Rueden CT, Hiner MC, Eliceiri KW. The ImageJ ecosystem: an open platform for biomedical image analysis. Mol Rep Dev 2015; 82: 518–529.